Nanomaterials in COPD: Emerging Therapeutic and Diagnostic Frontiers with a Focus on Metal–Organic Frameworks
International Journal of Molecular Sciences · 19.08.2025 · 26 (16) · 8025
DOI: 10.3390/ijms26168025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.08.2025. Verfasst von Antonio Tiralosi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Volunteers Organization, Via re Martino 84a, 95126 Catania, Italy. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Pulmonary Disease, Chronic Obstructive, Nanostructures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Catania.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide. Although conventional therapies are effective in controlling symptoms, they remain limited in altering the course of the disease and significantly reducing the chronic inflammation and oxidative stress underlying it. In this context, nanoparticles and nanomaterials are emerging as innovative tools capable of overcoming traditional pharmacological barriers due to their ability to deliver therapeutic oligonucleotides, antioxidants, and drugs in a targeted manner, modulate immune responses, and improve the bioavailability of active compounds. In particular, metal–organic frameworks (MOFs) stand out as ideal candidates for inhalable drug delivery in COPD, owing to their permanent crystalline porous structure, high specific surface area, and versatile chemical functionalization. This review provides the most recent preclinical evidence on the use of different nanoparticles in COPD, with a focus on the therapeutic and diagnostic potential of MOFs. It discusses their biocompatibility, drug loading strategies, and controlled release mechanisms and explores future perspectives for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Volunteers Organization, Via re Martino 84a, 95126 Catania, Italy.
- Section of Medical Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, Italy.
- Section of Pathology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
- Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
ORCID-Profile: Antonio Tiralosi, Vincenzo Paratore, Cristina Russo, Lucia Malaguarnera, Maria Stella Valle, Maria Teresa Cambria
Förderung
- University of Catania
Zitieren
APA
Tiralosi, A., Cambria, M., Campanella, M., Paratore, V., Russo, C., Malaguarnera, L., Valle, M. S., & Cambria, M. T. (2025). Nanomaterials in COPD: Emerging Therapeutic and Diagnostic Frontiers with a Focus on Metal–Organic Frameworks. International Journal of Molecular Sciences, 26(16), 8025. https://doi.org/10.3390/ijms26168025
Vancouver
Tiralosi A, Cambria M, Campanella M, Paratore V, Russo C, Malaguarnera L, et al. Nanomaterials in COPD: Emerging Therapeutic and Diagnostic Frontiers with a Focus on Metal–Organic Frameworks. International Journal of Molecular Sciences. 2025;26(16):8025. doi:10.3390/ijms26168025
BibTeX
@article{Tiralosi2025,
author = {Tiralosi, Antonio and Cambria, Manuela and Campanella, Mariachiara and Paratore, Vincenzo and Russo, Cristina and Malaguarnera, Lucia and Valle, Maria Stella and Cambria, Maria Teresa},
title = {Nanomaterials in COPD: Emerging Therapeutic and Diagnostic Frontiers with a Focus on Metal–Organic Frameworks},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {16},
pages = {8025},
doi = {10.3390/ijms26168025}
}
EUVIMED